TABLE 10. Estimated percent using inhaled short acting beta agonists among children1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2006-2010
State/Territory
Current
Active
Sample
size±
%
SE§
95% CI†
Sample
size
%
SE
95% CI
Arizona
125
46.8
7.3
(32.5 – 61.1)
149
40.1
6.4
(27.6 – 52.6)
California
170
57.0
5.1
(47.0 – 67.0)
206
51.2
4.8
(41.8 – 60.6)
Connecticut
347
53.6
3.6
(46.5 – 60.7)
413
47.4
3.3
(40.9 – 53.9)
District of Columbia
114
48.3
6.0
(36.5 – 60.1)
140
42.3
5.2
(32.1 – 52.5)
Georgia
341
43.3
3.7
(36.0 – 50.6)
399
38.9
3.3
(32.4 – 45.4)
Hawaii
417
34.6
2.9
(28.9 – 40.3)
444
33.5
2.8
(28.0 – 39.0)
Illinois
168
48.4
5.0
(38.6 – 58.2)
196
43.0
4.6
(34.0 – 52.0)
Indiana
348
46.9
3.6
(39.8 – 54.0)
391
40.3
3.3
(33.8 – 46.8)
Iowa
249
44.9
3.6
(37.8 – 52.0)
274
40.7
3.4
(34.0 – 47.4)
Kansas
588
53.8
2.4
(49.1 – 58.5)
657
48.8
2.3
(44.3 – 53.3)
Louisiana
107
32.2
5.4
(21.6 – 42.8)
122
29.5
5.0
(19.7 – 39.3)
Maine
284
54.8
3.4
(48.1 – 61.5)
332
47.2
3.1
(41.1 – 53.3)
Maryland
385
48.3
3.4
(41.6 – 55.0)
467
39.5
3.0
(33.6 – 45.4)
Massachusetts
269
46.6
4.5
(37.8 – 55.4)
315
41.8
4.0
(34.0 – 49.6)
Michigan
480
45.9
3.0
(40.0 – 51.8)
533
43.6
2.8
(38.1 – 49.1)
Mississippi
80
31.9
6.1
(19.9 – 43.9)
94
28.5
5.3
(18.1 – 38.9)
Missouri
230
51.2
4.7
(42.0 – 60.4)
255
46.1
4.5
(37.3 – 54.9)
Montana
210
46.7
4.4
(38.1 – 55.3)
253
42.2
4.0
(34.4 – 50.0)
Nebraska
467
47.2
3.9
(39.6 – 54.8)
528
43.4
3.7
(36.1 – 50.7)
New Hampshire
150
48.9
5.1
(38.9 – 58.9)
173
44.4
4.8
(35.0 – 53.8)
New Jersey
296
38.6
4.0
(30.8 – 46.4)
337
35.3
3.7
(28.0 – 42.6)
New Mexico
234
45.9
4.5
(37.1 – 54.7)
262
41.9
4.2
(33.7 – 50.1)
New York
276
42.7
4.2
(34.5 – 50.9)
336
35.4
3.7
(28.1 – 42.7)
North Dakota
98
46.7
5.7
(35.5 – 57.9)
120
36.7
5.1
(26.7 – 46.7)
Ohio
222
43.2
4.8
(33.8 – 52.6)
258
36.6
4.4
(28.0 – 45.2)
Oklahoma
250
53.0
3.9
(45.4 – 60.6)
256
52.4
3.9
(44.8 – 60.0)
Oregon
193
44.1
4.4
(35.5 – 52.7)
224
44.7
4.2
(36.5 – 52.9)
Pennsylvania
134
49.5
5.9
(37.9 – 61.1)
156
42.4
5.3
(32.0 – 52.8)
Rhode Island
153
51.5
4.8
(42.1 – 60.9)
180
47.8
4.4
(39.2 – 56.4)
Texas
479
41.5
3.8
(34.1 – 48.9)
558
34.9
3.3
(28.4 – 41.4)
Utah
368
49.4
3.7
(42.1 – 56.7)
414
46.2
3.5
(39.3 – 53.1)
Vermont
389
52.4
3.0
(46.5 – 58.3)
443
48.3
2.8
(42.8 – 53.8)
Virginia
88
44.7
6.6
(31.8 – 57.6)
100
42.6
6.2
(30.4 – 54.8)
Washington
341
49.0
3.5
(42.1 – 55.9)
389
44.4
3.3
(37.9 – 50.9)
West Virginia
193
48.6
4.3
(40.2 – 57.0)
213
45.3
4.0
(37.5 – 53.1)
Wisconsin
147
51.6
5.4
(41.0 – 62.2)
206
43.4
4.4
(34.8 – 52.0)
36 state total
9,390
46.8
1.1
(44.6 – 49.0)
10,793
41.5
1.1
(39.3 – 43.7)
Median
47.1
42.5
Range
31.9-57.0
28.5-52.4
1 Aged < 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Sample size is for multiple years of participation. Responses of “Don’t Know” and “Refused” are excluded.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.